4.7 Article

Removal of gemcitabine-induced senescent cancer cells by targeting glutaminase1 improves the therapeutic effect in pancreatic ductal adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

Junpei Yamaguchi et al.

Summary: This study aimed to clarify the feasibility and survival benefits of neoadjuvant chemotherapy in treating pancreatic cancer. Patients with borderline-resectable pancreatic cancer were randomly assigned to receive FOLFIRINOX or gemcitabine with nab-paclitaxel as neoadjuvant chemotherapy. The results showed that both regimens were well tolerated and achieved a high R0 resection rate, with favorable survival outcomes observed in the intention-to-treat analysis.

ANNALS OF SURGERY (2022)

Article Oncology

Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer

Suguru Mitsufuji et al.

Summary: This study found that CLU inhibition leads to cellular senescence in PDAC. Our findings suggest that CLU is a novel therapeutic target that contributes to the prognosis of PDAC by inducing cellular senescence.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders

Yoshikazu Johmura et al.

Summary: Research has shown that senescent cells rely on glutaminolysis for survival, and inhibiting this process can induce senolysis. Lysosomal membrane damage lowers intracellular pH in senescent cells, inducing KGA expression, leading to glutaminolysis, and ultimately producing ammonia to neutralize low pH and improve cell survival.

SCIENCE (2021)

Article Oncology

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells

Jing Guo et al.

Summary: The study revealed that increased synthesis of GSH from glutamine via DNA methylation-mediated silencing of GS causes CDDP resistance in A2780cis cells. Targeting glutamine metabolism could be a potential therapeutic approach to overcome CDDP resistance.

BMC CANCER (2021)

Review Oncology

Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer

Cecilia R. Chambers et al.

Summary: Senescence is a cellular state where cells halt the cell cycle in response to stress, with senescent cancer cells and adjacent cells potentially remaining metabolically active and secreting pro-inflammatory factors known as the SASP. The SASP plays a critical role in tumorigenesis, affecting various processes and treatment efficacy. Future research on therapy-induced senescence and pharmacological manipulation may provide new avenues for cancer therapeutics.

MOLECULAR ONCOLOGY (2021)

Article Cell Biology

The Cancer SENESCopedia: A delineation of cancer cell senescence

Fleur Jochems et al.

Summary: The study comprehensively analyzed the transcriptome and senolytic responses in 13 cancer cell lines induced to undergo senescence, showing that the response to senolytic agents and the composition of the senescence-associated secretory phenotype in cancer cells are more influenced by the cell of origin than by the senescence trigger. Using machine learning, a gene expression classifier called SENCAN was established for detecting senescence in cancer cell samples, with the expression profiles and classifier accessible online as Cancer SENESCopedia.

CELL REPORTS (2021)

Review Cell Biology

The role of glutaminase in cancer

Brendah K. Masisi et al.

HISTOPATHOLOGY (2020)

Article Biochemistry & Molecular Biology

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Marcus Ruscetti et al.

Article Biochemistry & Molecular Biology

The senescence-associated secretory phenotype and its regulation

Stephane Lopes-Paciencia et al.

CYTOKINE (2019)

Article Cell Biology

Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes

Cristina Aguayo-Mazzucato et al.

CELL METABOLISM (2019)

Review Biochemistry & Molecular Biology

Chemoresistance in Pancreatic Cancer

Siyuan Zeng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Senescence-associated reprogramming promotes cancer stemness

Maja Milanovic et al.

NATURE (2018)

Review Urology & Nephrology

Cellular senescence in renal ageing and disease

Ines Sturmlechner et al.

NATURE REVIEWS NEPHROLOGY (2017)

Article Biochemistry & Molecular Biology

Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice

Jianhui Chang et al.

NATURE MEDICINE (2016)

Review Medicine, General & Internal

Pancreatic cancer

Terumi Kamisawa et al.

LANCET (2016)

Article Multidisciplinary Sciences

Naturally occurring p16Ink4a-positive cells shorten healthy lifespan

Darren J. Baker et al.

NATURE (2016)

Article Multidisciplinary Sciences

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Amira Elgogary et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Senescent intimal foam cells are deleterious at all stages of atherosclerosis

Bennett G. Childs et al.

SCIENCE (2016)

Article Oncology

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

Y. Iwagami et al.

BRITISH JOURNAL OF CANCER (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Oncology

Therapy-Induced Senescence in Cancer

Jonathan A. Ewald et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Review Oncology

SENESCENCE Senescence in tumours: evidence from mice and humans

Manuel Collado et al.

NATURE REVIEWS CANCER (2010)

Article Multidisciplinary Sciences

The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis

Gong Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Cell Biology

Complexity and species variation of the kidney-type glutaminase gene

LD Porter et al.

PHYSIOLOGICAL GENOMICS (2002)

Article Biochemistry & Molecular Biology

Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53

A Seluanov et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)